Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells in emphysema
NL-OMON21186Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of mesenchymal stem cells in emphysema and chronic obstructive pulmonary disease (COPD) (3 cohorts), sponsored by University Medical Center Groningen. Primary endpoints: Successful isolation and culturing of mesenchymal stem cells derived from lung tissue and Successful isolation and culturing of mesenchymal stem cells derived from adipose tissue. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
emphysemachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON21186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21186.